products' full potential benefits through unparalleled support and collaborations The Principals invested --$30.0M to date. Other investors included D.E. Shaw and related entities and Rich Fricsner Nimbus Nimbus Discovery uses computational technology to develop medicines against hard-to-drug targets. N